Karolinska Development AB

Karolinska Development invests in new innovative treatments for life-threatening diseases.

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.

 

Kategorier: Investors & Venture Capitalists

Gå till Karolinska Development ABs hemsida